RPN2 and gastric cancer: Other experiment showed that the expression of P-gp protein was decreased upon cisplatin treatment in RPN2-knockdown gastric cancer cell lines compared to control gastric cancer cell lines, and the viability of RPN2-knockdown gastric cancer cell lines were reduced relative to control gastric cancer cell lines in the presence of cisplatin [15].